Key result
Non-traditional cardiovascular risk markers are needed to reliably predict future cardiovascular disease and enable individualized treatment in patients lacking traditional risk factors.
Answers are grounded in this paper and cite their sources.
Highlights the clinical need for non-traditional cardiovascular risk markers to better predict and prevent first-time CVD events in patients whose traditional risk factors do not indicate high risk.
In relatively young patients (men <55 and women >65 years of age), first-time hospitalisation for cardiovascular disease (CVD) strikes without warning since the traditional cardiovascular risk factors are often normal or only slightly elevated. Therefore, we need non-traditional cardiovascular risk markers more closely related to CVD that can reliably predict future CVD in individuals, making better targeted prevention and more individualised treatment possible. However, it has been difficult to find non-traditional cardiovascular risk markers suitable for risk assessment, underlining the importance of future research into the complex mechanisms that lead to CVD. Better understanding of these complex mechanisms might enable us to find better risk markers and improve future cardiovascular risk assessment and treatment.
No takes yet. Share an insight, caveat, or question.
Michael Hecht Olsen (2010) conducted a review in Cardiovascular disease. Non-traditional cardiovascular risk markers was evaluated. Non-traditional cardiovascular risk markers are needed to reliably predict future cardiovascular disease and enable individualized treatment in patients lacking traditional risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: